iomeprol · Bracco · NDA 216016, 216017
Iomervu
Earliest generic entry, as listed · earliest of 8 marketed strengths
27 Nov 2029
Blocked by exclusivity: NCE.
Listed patents · 0 unexpired
No unexpired patents listed.
Exclusivities · 1 unexpired
| NCE | new chemical entity (5 years) | 27 Nov 2029 |
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.
Products covered · 26
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 216016 · 001 · RLD · discontinued | solution, intra-arterial | 25GM IODINE/100ML (250MG IODINE/ML) | 27 Nov 2029 |
| 216016 · 002 · RLD · discontinued | solution, intra-arterial | 15GM IODINE/50ML (300MG IODINE/ML) | 27 Nov 2029 |
| 216016 · 003 · RLD · discontinued | solution, intra-arterial | 30GM IODINE/100ML (300MG IODINE/ML) | 27 Nov 2029 |
| 216016 · 004 · RLD · discontinued | solution, intra-arterial | 45GM IODINE/150ML (300MG IODINE/ML) | 27 Nov 2029 |
| 216016 · 005 · RLD · discontinued | solution, intra-arterial | 60GM IODINE/200ML (300MG IODINE/ML) | 27 Nov 2029 |
| 216016 · 006 · RLD · discontinued | solution, intra-arterial | 17.5GM IODINE/50ML (350MG IODINE/ML) | 27 Nov 2029 |
| 216016 · 007 · RLD | solution, intra-arterial | 35GM IODINE/100ML (350MG IODINE/ML) | 27 Nov 2029 |
| 216016 · 008 · RLD · discontinued | solution, intra-arterial | 52.5GM IODINE/150ML (350MG IODINE/ML | 27 Nov 2029 |
| 216016 · 009 · RLD | solution, intra-arterial | 70GM IODINE/200ML (350MG IODINE/ML) | 27 Nov 2029 |
| 216016 · 010 · RLD · discontinued | solution, intra-arterial | 20GM IODINE/50ML (400MG IODINE/ML) | 27 Nov 2029 |
| 216016 · 011 · RLD | solution, intra-arterial | 40GM IODINE/100ML (400MG IODINE/ML) | 27 Nov 2029 |
| 216016 · 012 · RLD · discontinued | solution, intra-arterial | 60GM IODINE/150ML (400MG IODINE/ML) | 27 Nov 2029 |
| 216016 · 013 · RLD | solution, intra-arterial | 80GM IODINE/200ML (400MG IODINE/ML) | 27 Nov 2029 |
| 216017 · 001 · RLD · discontinued | solution, intravenous | 25GM IODINE/100ML (250MG IODINE/ML) | 27 Nov 2029 |
| 216017 · 002 · RLD · discontinued | solution, intravenous | 15GM IODINE/50ML (300MG IODINE/ML) | 27 Nov 2029 |
| 216017 · 003 · RLD · discontinued | solution, intravenous | 30GM IODINE/100ML (300MG IODINE/ML) | 27 Nov 2029 |
| 216017 · 004 · RLD · discontinued | solution, intravenous | 45GM IODINE/150ML (300MG IODINE/ML) | 27 Nov 2029 |
| 216017 · 005 · RLD · discontinued | solution, intravenous | 60GM IODINE/200ML (300MG IODINE/ML) | 27 Nov 2029 |
| 216017 · 006 · RLD · discontinued | solution, intravenous | 17.5GM IODINE/50ML (350MG IODINE/ML) | 27 Nov 2029 |
| 216017 · 007 · RLD | solution, intravenous | 35GM IODINE/100ML (350MG IODINE/ML) | 27 Nov 2029 |
| 216017 · 008 · RLD · discontinued | solution, intravenous | 52.5GM IODINE/150ML (350MG IODINE/ML) | 27 Nov 2029 |
| 216017 · 009 · RLD | solution, intravenous | 70GM IODINE/200ML (350MG IODINE/ML) | 27 Nov 2029 |
| 216017 · 010 · RLD · discontinued | solution, intravenous | 20GM IODINE/50ML (400MG IODINE/ML) | 27 Nov 2029 |
| 216017 · 011 · RLD | solution, intravenous | 40GM IODINE/100ML (400MG IODINE/ML) | 27 Nov 2029 |
| 216017 · 012 · RLD · discontinued | solution, intravenous | 60GM IODINE/150ML (400MG IODINE/ML) | 27 Nov 2029 |
| 216017 · 013 · RLD | solution, intravenous | 80GM IODINE/200ML (400MG IODINE/ML) | 27 Nov 2029 |